VIDEO INVESTIGATOR INTERVIEW

TIDES ACS is the first randomised trial to compare the novel Optimax bioactive stent against the Synergy drug eluting stent.

Optimax is a cobalt chromium metal stent with an active coating of titanium nitride oxide, and it is matched against an everolimus drug eluting stent, “the best drug eluting stent currently on the market”, believes investigator Parsi Karjalainen.